Table 1 Clinical Data

From: Small Lymphocytic Lymphoma with Perifollicular, Marginal Zone, or Interfollicular Distribution

Case

Sex

Age (yr)

Biopsy Site

WBC (/mm3)

Pattern of Involvement

BM

Liver

Spleen

Stage

Rx

Status

Other

1

F

38

Cervical

8900

IF

Y

N

Y

IV

CT

AWD

CMV, EBV

2

M

60

Cervical

7200

IF

N

N

Y

III

CT

AWD

 

3

F

68

Cervical

8600

IF

Y

N

N

IV

No

AWD

 

4

F

69

Cervical

8800

IF

N

N

N

NA

RT

AWD

History of breast cancer

5

F

88

Axilla

6200

IF

Y

N

N

IV

No

AWD

 

6

F

68

Inguinal

5000

IF

N

N

N

III

No

AWD

 

7

F

76

Cervical

9000

IF

N

N

N

NA

No

AWD

 

8

M

70

Colon

11200

PF/IF

Y

N

N

IV

No

AWD

Colonic adenoCA

9

M

45

Inguinal

3000

MZ/D*

Y

Y

Y

IV

No

AWD

 

10

M

74

Cervical

20000

IF

N

N

N

NA

No

AWD

 

11

M

66

Cervical

5700

IF

Y

N

N

IV

CT

AWD

 

12

F

71

Cervical

NA

MZ

Y

N

N

IV

CT

AWD

 

13

M

67

Cervical

10000

IF

Y

Y

Y

IV

CT

AWOD

 

14

M

60

Inguinal

30000

IF

Y

N

N

IV

CT

AWD

 

15

M

66

Cervical

10000

MZ/D*

Y

Y

N

N

IV

CT

AWD History of LBCL

16

F

64

Cervical

10000

IF

N

N

N

NA

No

AWD

 
  1. AWD, alive with disease; AWOD, alive without disease; DWD, dead with disease; BM, bone marrow; CMT, chemotherapy; Rx, treatment; IF, interfollicular; MZ, marginal zone pattern; PF, perifollicular; LBCL, large B-cell lymphoma; NA, not available; D*, diffuse involvement in a subsequently available lymph node specimen.